Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study

Patients with non-small cell lung cancer (NSCLC) frequently develop brain metastases (BM) [1]. In patients with stage III NSCLC staged with a magnetic resonance imaging (MRI) or computed tomography (CT) scan of the brain, the incidence of BM is currently around 30%, and prognosis is typically poor [1]. Once BM have occurred, patients are treated with the intention to maintain their health-related quality of life (HRQoL) during their remaining lifespan [2].

Source: Radiotherapy and Oncology - November 12, 2019 Category: Radiology Authors: W.J.A. Witlox, B.L.T. Ramaekers, M.A. Joore, A.-M.C. Dingemans, J. Praag, J. Belderbos, C. Tissing-Tan, G. Herder, T. Haitjema, J.F. Ubbels, J. Lagerwaard, S.Y. El Sharouni, J.A. Stigt, E.F. Smit, H. van Tinteren, V. van der Noort, H.J.M. Groen, D.K.M. De Tags: Original Article Source Type: research